Medidata Solutions (NASDAQ:MDSO) announced its earnings results on Thursday. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.05, Bloomberg Earnings reports. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The business had revenue of $149.20 million during the quarter, compared to analysts’ expectations of $146.73 million. During the same period in the prior year, the company earned $0.31 earnings per share. The business’s revenue was up 16.9% compared to the same quarter last year.
NASDAQ MDSO opened at $69.75 on Thursday. Medidata Solutions has a 52-week low of $59.60 and a 52-week high of $85.92. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a market cap of $4,101.90, a P/E ratio of 82.06, a PEG ratio of 3.64 and a beta of 1.53.
A number of equities research analysts have recently commented on the stock. Morgan Stanley reduced their target price on shares of Medidata Solutions from $86.00 to $79.00 and set an “overweight” rating for the company in a report on Friday, February 9th. ValuEngine cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. TheStreet raised shares of Medidata Solutions from a “c+” rating to a “b-” rating in a report on Monday, March 12th. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Thursday, April 12th. Finally, BidaskClub raised shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Medidata Solutions currently has an average rating of “Buy” and an average price target of $82.36.
Institutional investors have recently modified their holdings of the business. Summit Creek Advisors LLC purchased a new position in Medidata Solutions in the fourth quarter valued at about $5,137,000. KAMES CAPITAL plc increased its holdings in Medidata Solutions by 54.6% in the fourth quarter. KAMES CAPITAL plc now owns 25,521 shares of the company’s stock valued at $1,617,000 after buying an additional 9,012 shares in the last quarter. New Mexico Educational Retirement Board purchased a new position in Medidata Solutions in the fourth quarter valued at about $919,000. Quadrature Capital Ltd purchased a new position in Medidata Solutions in the fourth quarter valued at about $992,000. Finally, Deutsche Bank AG increased its holdings in Medidata Solutions by 10.5% in the fourth quarter. Deutsche Bank AG now owns 278,714 shares of the company’s stock valued at $17,659,000 after buying an additional 26,425 shares in the last quarter.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.